http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1494577-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c771726e89b709f93b922aba311e8a0 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-6824 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7203 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7264 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0059 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-1455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00 |
filingDate | 2003-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b914cb59d7eb141eb31c295272f1584 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e15b674144350d4376c8a2c838616dde http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7acccdfe56cd38510a110a8b9afd1705 |
publicationDate | 2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1494577-B1 |
titleOfInvention | Spectroscopic analysis of tissue to detect diabetes |
abstract | Apparatus and methods for spectroscopic analysis of human tissue to classify an individual as diabetic or non-diabetic, or to determine the probability, progression or level of diabetes in an individual. Tissue optical information of an individual, including at least a measurement of at least one wavelength or group of wavelengths indicative of glycosylated collagen content in tissue, is analyzed using multivariate techniques. The multivariate techniques include an algorithm developed from optical information from individuals having a known disease state. At least one factor in the algorithm is dependent on or a function of the measurement of the at least one wavelength or group of wavelengths indicative of glycosylated collagen content in tissue. The device includes an illumination subsystem (100), a tissue sampling (200), an FTIR spectrometer subsystem (400), a data acquisition subsystem (500), an embedded processing subsystem (600), and a calibration maintenance subsystem (300). |
priorityDate | 2002-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.